Bernitsas Law acted as Greek law counsel to Partners Group on their acquisition of Pharmathen from the international investment firm BC Partners. The transaction values Pharmathen at an enterprise value of around €1.6bn. We also advised Partners Group in connection with various facilities agreements and security arrangements.
Partners Group is a leading global private markets firm, having invested over $170 bn in private equity, private debt, private real estate, and private infrastructure globally.
Pharmathen is a leading European pharmaceutical company, specialized in drug delivery technologies for complex generic pharma products.
Partners Lambros Belessis and Evi Kitsou led the Corporate and M&A team. Partner Athanasia Tsene advised on Banking and Finance, Partner Yannis Chryssospathis and Senior Associate Ria Venaki advised on Life Sciences and Healthcare.
Counsel Linda Vasaka led the due diligence team.